Clinical Trials Directory

Trials / Unknown

UnknownNCT04271124

COPD and Inflammatory Mediators

Comparison of Exercise Training

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Faculty of Medicine, Sousse · Academic / Other
Sex
Male
Age
50 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Chronic obstructive pulmonary disease (COPD) is widely spread all over the world. It is predicted to be the third leading cause of death by 2020.

Detailed description

COPD is a common, preventable treatable disease that is characterized by an airflow limitation which is not fully reversible.Not only the long-term exposition to noxious particles and gases contributes to the development of COPD, but also many others factors such as genetics and cigarette smoking. Cigarettes are harmful and contribute to different extra pulmonary disorders. Although COPD affects lungs some extrapulmonary manifestations are prescribed such as muscle dysfunction, abnormal respiratory muscles and systemic inflammation. Indeed, the systemic inflammation\[6, 8\] is considered as a key process in the pathogenesis of COPD. It involves different cells and molecules; high levels of circulating of white blood cells, increased plasma c-reactive proteins (CRP), interleukin 6 (Il6) have been reported in.those patients.Likewise, systemic inflammation could worsen the comorbidities (cardiovascular, osteoporosis..) and may lead to the exercise limitation.

Conditions

Interventions

TypeNameDescription
OTHERexercise trainingThe patients are allocated to PR+ET group or PR Each group receive an exercise training

Timeline

Start date
2020-05-01
Primary completion
2020-07-01
Completion
2020-07-01
First posted
2020-02-17
Last updated
2020-02-17

Locations

1 site across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT04271124. Inclusion in this directory is not an endorsement.